GED0301: Clinical Trials

3 trials of GED0301, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 1 withdrawn. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Terminated 2, Withdrawn 1

Follow GED0301: new trials by email Literature Review of GED0301 trials Research Report on GED0301

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Efficacy and Safety of Mongersen (GED-0301) for the Treatment of Adult and Adolescent Subjects With Active Crohn's Disease
GED-0301, Placebo - Crohn Disease
Phase 3WithdrawnCelgene2017-12-012017-11-14
A Long-term Active Treatment Study of Mongersen (GED-0301) in Subjects With Crohn's Disease
GED-0301, Placebo - Crohn's Disease
Phase 3TerminatedCelgene3102016-07-252019-01-29
Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease
GED-0301, Placebo - Crohn Disease
Phase 3TerminatedCelgene7012015-12-082019-08-28

Conditions studied

Crohn Disease (3)  ·  Irritable Bowel Syndrome (1)

Sponsors

Celgene (3)

Countries

Australia (3)  ·  Austria (3)  ·  Belgium (3)  ·  Canada (3)  ·  Croatia (3)  ·  Czechia (3)  ·  Denmark (3)  ·  France (3)  ·  Germany (3)  ·  Greece (3)  ·  Hungary (3)  ·  Israel (3)  ·  Italy (3)  ·  Latvia (3)  ·  Netherlands (3)

Top investigators

Guillermo Rossiter, MD (2)  ·  Denesh Chitkara, MD (1)

Results publications

PMID 31850931